Display options
Share it on

Curr Oncol. 2014 Jun;21(3):e480-92. doi: 10.3747/co.21.1829.

The role of interventional radiology in the management of hepatocellular carcinoma.

Current oncology (Toronto, Ont.)

N Molla, N AlMenieir, E Simoneau, M Aljiffry, D Valenti, P Metrakos, L M Boucher, M Hassanain

Affiliations

  1. Department of Radiology, King Saud University, Riyadh, Saudi Arabia. ; Section of Hepatopancreatobiliary and Transplant Surgery, McGill University Health Centre, Montreal, QC.
  2. Department of Radiology, King Saud University, Riyadh, Saudi Arabia.
  3. Section of Hepatopancreatobiliary and Transplant Surgery, McGill University Health Centre, Montreal, QC.
  4. Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia.
  5. Department of Radiology, McGill University Health Centre, Montreal, QC.
  6. Section of Hepatopancreatobiliary and Transplant Surgery, McGill University Health Centre, Montreal, QC. ; Department of Surgery, King Saud University, Riyadh, Saudi Arabia.

PMID: 24940108 PMCID: PMC4059812 DOI: 10.3747/co.21.1829

Abstract

BACKGROUND: Hepatocellular carcinoma (hcc) is one of the most common causes of cancer-related death worldwide. Overall, liver transplantation and resection are the only available treatments with potential for cure. Various locoregional therapies are widely used to manage patients with advanced hcc or as a bridging therapy for patients with early and intermediate disease. This article reviews and evaluates the role of interventional radiology in the management of such cases by assessing various aspects of each method, such as effect on rates of survival, recurrence, tumour response, and complications.

METHODS: A systemic search of PubMed, medline, Ovid Medline In-Process, and the Cochrane Database of Systematic Reviews retrieved all related scientific papers for review.

RESULTS: Needle core biopsy is a highly sensitive, specific, and accurate method for hcc grading. Portal-vein embolization provides adequate expansion of the future liver remnant, making more patients eligible for resection. In focal or multifocal unresectable early-stage disease, radiofrequency ablation tops all other thermoablative methods. However, microwave ablation is preferred in large tumours and in patients with Child-Pugh B disease. Cryoablation is preferred in recurrent disease and in patients who are poor candidates for anesthesia. Of the various transarterial modalities-transarterial chemoembolization (tace), drug-eluting beads, and transarterial radio-embolization (tare)-tace is the method of choice in Child-Pugh A disease, and tare is the method of choice in hcc cases with portal vein thrombosis.

CONCLUSIONS: The existing data support the importance of a multidisciplinary approach in hcc management. Large randomized controlled studies are needed to provide clear indication guidelines for each method.

Keywords: Interventional radiology; ablation; drug-eluting beads; embolization; hepatocellular carcinoma; liver biopsy

References

  1. Radiology. 2000 Mar;214(3):761-8 - PubMed
  2. J Hepatol. 2008 Oct;49(4):589-94 - PubMed
  3. Liver Int. 2007 Nov;27(9):1166-73 - PubMed
  4. J Hepatol. 2011 Feb;54(2):300-5 - PubMed
  5. J Surg Oncol. 2009 Dec 15;100(8):619-34 - PubMed
  6. Radiology. 2003 Feb;226(2):441-51 - PubMed
  7. J Vasc Interv Radiol. 2010 Aug;21(8):1213-8 - PubMed
  8. J Surg Oncol. 1991 Dec;48(4):246-51 - PubMed
  9. World J Surg. 1999 Feb;23(2):109-13; discussion 113-4 - PubMed
  10. J Hepatol. 2005 Oct;43(4):563-8 - PubMed
  11. J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S342-7 - PubMed
  12. Am J Gastroenterol. 2007 Jun;102(6):1216-20 - PubMed
  13. Oncology. 2007;72 Suppl 1:124-31 - PubMed
  14. Ann Surg. 2003 Feb;237(2):208-17 - PubMed
  15. Liver Transpl. 2000 Sep;6(5):619-26 - PubMed
  16. Ann Surg. 2007 Sep;246(3):385-92; discussion 392-4 - PubMed
  17. Gastroenterol Hepatol (N Y). 2011 May;7(5):313-6 - PubMed
  18. AJR Am J Roentgenol. 2003 Nov;181(5):1327-34 - PubMed
  19. Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1209-13 - PubMed
  20. Scand J Gastroenterol. 1989 Oct;24(8):949-55 - PubMed
  21. Gut. 2002 Jun;50(6):881-5 - PubMed
  22. Acta Cytol. 2003 May-Jun;47(3):332-6 - PubMed
  23. AJR Am J Roentgenol. 2010 Mar;194(3):830-7 - PubMed
  24. J Hepatol. 2012;56 Suppl 1:S75-87 - PubMed
  25. Hong Kong Med J. 2012 Apr;18(2):85-91 - PubMed
  26. Indian J Radiol Imaging. 2013 Apr;23(2):126-33 - PubMed
  27. Cancer Res. 1988 May 1;48(9):2446-50 - PubMed
  28. Cancer. 1996 May 1;77(9):1792-6 - PubMed
  29. J Hepatol. 2003 Aug;39(2):239-44 - PubMed
  30. Hepatology. 2002 May;35(5):1164-71 - PubMed
  31. Hepatology. 2011 Sep 2;54(3):868-78 - PubMed
  32. Br J Surg. 2006 Apr;93(4):440-7 - PubMed
  33. J Vasc Interv Radiol. 2003 Oct;14(10):1267-74 - PubMed
  34. J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):332-41 - PubMed
  35. Acta Cytol. 2004 Mar-Apr;48(2):142-8 - PubMed
  36. Abdom Imaging. 2008 Sep-Oct;33(5):512-9 - PubMed
  37. Invest Radiol. 1990 Mar;25(3):267-70 - PubMed
  38. Cardiovasc Intervent Radiol. 2008 May-Jun;31(3):468-76 - PubMed
  39. Liver Transpl. 2004 Feb;10(2 Suppl 1):S107-10 - PubMed
  40. Am J Gastroenterol. 2009 Feb;104(2):514-24 - PubMed
  41. Cancer Control. 2010 Apr;17(2):87-99 - PubMed
  42. AJR Am J Roentgenol. 2007 Apr;188(4):1028-32 - PubMed
  43. Hepatology. 2010 Nov;52(5):1741-9 - PubMed
  44. Eur J Gastroenterol Hepatol. 2009 Jun;21(6):599-605 - PubMed
  45. Gut. 2008 Nov;57(11):1592-6 - PubMed
  46. Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):919-24 - PubMed
  47. HPB (Oxford). 2011 Mar;13(3):168-73 - PubMed
  48. J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S219-S226, S226.e1-10 - PubMed
  49. Radiology. 1999 Mar;210(3):655-61 - PubMed
  50. J Vasc Interv Radiol. 2007 Feb;18(2):283-7 - PubMed
  51. Zhonghua Gan Zang Bing Za Zhi. 2011 Oct;19(10):759-63 - PubMed
  52. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  53. J Urol. 1961 Sep;86:321-9 - PubMed
  54. Ann Surg. 2000 Sep;232(3):381-91 - PubMed
  55. Curr Oncol. 2010 Oct;17(5):67-9 - PubMed
  56. Ann Oncol. 2010 May;21 Suppl 5:v59-64 - PubMed
  57. Diagn Cytopathol. 2000 Nov;23(5):326-8 - PubMed
  58. Acta Radiol. 1995 Sep;36(5):485-90 - PubMed
  59. Hepatogastroenterology. 2003 Jan-Feb;50(49):183-7 - PubMed
  60. Nucl Med Biol. 1995 Apr;22(3):379-86 - PubMed
  61. Semin Liver Dis. 2010 Feb;30(1):52-60 - PubMed
  62. Arch Surg. 2000 Jun;135(6):657-62; discussion 662-4 - PubMed
  63. Hepatology. 2009 Nov;50(5):1475-83 - PubMed
  64. J Vasc Interv Radiol. 2010 Aug;21(8):1205-12 - PubMed
  65. HPB (Oxford). 2012 Jul;14(7):461-8 - PubMed
  66. Liver Transpl. 2000 Jan;6(1):67-72 - PubMed
  67. Int J Hyperthermia. 2010;26(5):448-55 - PubMed
  68. Cancer Treat Rev. 2007 Aug;33(5):437-47 - PubMed
  69. Radiology. 2005 Oct;237(1):366-70 - PubMed
  70. World J Surg. 2012 Jul;36(7):1640-6 - PubMed
  71. J Surg Oncol. 1990 Jun;44(2):109-14 - PubMed
  72. Int J Med Sci. 2008;5(6):327-32 - PubMed
  73. Am J Clin Pathol. 2006 May;125(5):710-21 - PubMed
  74. Hepatogastroenterology. 2013 Jul-Aug;60(125):1131-5 - PubMed
  75. Hepatology. 2003 Dec;38(6):1449-57 - PubMed
  76. Hepatology. 1997 Nov;26(5):1156-61 - PubMed
  77. J Hepatol. 2001 Aug;35(2):254-8 - PubMed
  78. Dig Liver Dis. 2009 Feb;41(2):143-9 - PubMed
  79. J Hepatol. 1996 Sep;25(3):334-8 - PubMed
  80. Technol Cancer Res Treat. 2007 Aug;6(4):307-12 - PubMed
  81. Arch Surg. 2002 Jun;137(6):675-80; discussion 680-1 - PubMed
  82. Lancet. 2002 May 18;359(9319):1734-9 - PubMed
  83. Gastroenterology. 2011 Feb;140(2):497-507.e2 - PubMed
  84. Gut. 2005 Aug;54(8):1151-6 - PubMed
  85. Liver Transpl. 2005 Sep;11(9):1117-26 - PubMed
  86. J Vasc Interv Radiol. 2009 Jan;20(1):3-8 - PubMed
  87. Cardiovasc Intervent Radiol. 2009 Jul;32(4):727-36 - PubMed
  88. Cancer. 2002 Mar 15;94(6):1747-52 - PubMed
  89. J Nucl Med. 1994 Nov;35(11):1782-7 - PubMed
  90. Clin Radiol. 2013 Jan;68(1):21-6 - PubMed
  91. Int J Hepatol. 2013;2013:174103 - PubMed
  92. Am J Gastroenterol. 1994 Jun;89(6):898-902 - PubMed
  93. J Hepatol. 2007 Mar;46(3):474-81 - PubMed
  94. Radiology. 2009 Jun;251(3):933-40 - PubMed
  95. J Clin Oncol. 2002 Nov 15;20(22):4459-65 - PubMed
  96. J Hepatol. 2009 Dec;51(6):981-3 - PubMed
  97. J Surg Oncol. 2013 Apr;107(5):544-9 - PubMed
  98. Ann Surg. 2000 Nov;232(5):665-72 - PubMed
  99. Hepatology. 2011 Mar;53(3):1020-2 - PubMed
  100. Dig Dis Sci. 2010 Sep;55(9):2450-8 - PubMed
  101. Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52 - PubMed
  102. Cytojournal. 2005 Jun 08;2:7 - PubMed
  103. Radiology. 1989 Mar;170(3 Pt 1):783-6 - PubMed
  104. J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):335-42 - PubMed
  105. J Urol. 2003 Aug;170(2 Pt 1):619-22 - PubMed
  106. Hepatol Int. 2009 Mar;3(1):283-93 - PubMed
  107. Hepatology. 2009 Feb;49(2):658-64 - PubMed
  108. J Trauma. 1983 Dec;23(12):1061-5 - PubMed
  109. J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S101-8 - PubMed
  110. Cancer. 1990 Nov 1;66(9):1897-903 - PubMed
  111. Gastroenterology. 2010 Jan;138(1):52-64 - PubMed
  112. Int J Surg. 2011;9(2):188-91 - PubMed
  113. Cancer. 1994 Jul 1;74(1):16-24 - PubMed
  114. Eur J Surg Oncol. 2008 May;34(5):541-6 - PubMed
  115. J Hepatol. 1990 Nov;11(3):344-8 - PubMed
  116. Cancer Treat Rev. 2012 Feb;38(1):54-62 - PubMed

Publication Types